APGE logo

APGE
Apogee Therapeutics

443
Mkt Cap
$6.24B
Volume
472,565.00
52W High
$95.32
52W Low
$34.34
PE Ratio
-19.67
APGE Fundamentals
Price
$80.75
Prev Close
$82.89
Open
$83.99
50D MA
$78.58
Beta
0.00
Avg. Volume
1.31M
EPS (Annual)
-$4.22
P/B
6.27
Rev/Employee
$0.00
$3,859.60
Loading...
Loading...
News
all
press releases
Pictet Asset Management Holding SA Takes $23.62 Million Position in Apogee Therapeutics Inc. $APGE
Pictet Asset Management Holding SA bought a new stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent filing with the Securities...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Reaches New 1-Year High - Still a Buy?
Apogee Therapeutics (NASDAQ:APGE) Reaches New 52-Week High - Time to Buy...
MarketBeat·17d ago
News Placeholder
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seventeen brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recomme...
MarketBeat·20d ago
News Placeholder
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $82.58, for a total transaction of $1,651,600.00. Following the completion of the...
MarketBeat·21d ago
News Placeholder
Aberdeen Group plc Lowers Stake in Apogee Therapeutics Inc. $APGE
Aberdeen Group plc lessened its stake in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 34.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional...
MarketBeat·22d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Still a Buy?
Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High - Should You Buy...
MarketBeat·22d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Insider Sells $466,620.00 in Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average...
MarketBeat·28d ago
News Placeholder
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $84.84, for a total transaction of $466,620.00. Following the transaction, the insider directly...
MarketBeat·28d ago
News Placeholder
Banque Pictet & Cie SA Invests $3.16 Million in Apogee Therapeutics Inc. $APGE
Banque Pictet & Cie SA purchased a new position in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the...
MarketBeat·29d ago
News Placeholder
SG Americas Securities LLC Sells 60,964 Shares of Apogee Therapeutics Inc. $APGE
SG Americas Securities LLC cut its stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 45.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,262 shares of the company's stock after selling 60,96...
MarketBeat·30d ago
<
1
2
...
>

Latest APGE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.